Overall, these findings extend the understanding of environmental pollutant-induced metabolic disorders and identify the hepatic AhR–PAI-1 axis as a potential therapeutic target for obesity and related metabolic diseases. This evidence concerns the gene SERPINE1 and metabolic disease.